First Time Loading...

Arcturus Therapeutics Holdings Inc
NASDAQ:ARCT

Watchlist Manager
Arcturus Therapeutics Holdings Inc Logo
Arcturus Therapeutics Holdings Inc
NASDAQ:ARCT
Watchlist
Price: 26.55 USD 1.45% Market Closed
Updated: Apr 27, 2024
Section:
 

Wall Street
Price Targets

ARCT Price Targets Summary
Arcturus Therapeutics Holdings Inc

Wall Street analysts forecast ARCT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ARCT is 68.98 USD with a low forecast of 18.18 USD and a high forecast of 147 USD.

ARCT Lowest Forecast
Wall Street Target
18.18 USD
32% Downside
ARCT Average Forecast
Wall Street Target
68.98 USD
160% Upside
ARCT Highest Forecast
Wall Street Target
147 USD
454% Upside
Lowest
Price Target
18.18 USD
32% Downside
Average
Price Target
68.98 USD
160% Upside
Highest
Price Target
147 USD
454% Upside

ARCT Last Price Targets
Arcturus Therapeutics Holdings Inc

The latest public price target was made on Mar 19, 2024 by Yale Jen from Laidlaw , who expects ARCT stock to rise by 198% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst Price Target Date Article
Yale Jen
Laidlaw
79 USD
Upside 198%
1 month ago
Mar 19, 2024
Laidlaw Reiterates Buy Rating on Arcturus Therapeutics (ARCT)
StreetInsider
Yale Jen
Laidlaw
Price Target 79 USD
Upside/Downside 198%
View Source
Arcturus Therapeutics Holdings Inc Competitors:
Price Targets
87S
Roivant Sciences Ltd
48% Upside
GILD
Gilead Sciences Inc
32% Upside
i
048530
iNtRON Biotechnology Inc
138% Upside
C
CBUS
Cibus Inc
48% Upside
87S
Roivant Sciences Ltd
48% Upside
GILD
Gilead Sciences Inc
32% Upside
i
048530
iNtRON Biotechnology Inc
138% Upside
C
CBUS
Cibus Inc
48% Upside
OVID
Ovid Therapeutics Inc
141% Upside
T
1875
TOT BIOPHARM International Co Ltd
131% Upside
688520
Sinocelltech Group Ltd
62% Upside
MYGN
Myriad Genetics Inc
37% Upside

Revenue
Forecast

Revenue Estimate
Arcturus Therapeutics Holdings Inc

The compound annual growth rate of Arcturus Therapeutics Holdings Inc's revenue for the next 3 years is 45%.

N/A
Past Growth
45%
Estimated Growth
Estimates Accuracy
-5%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Arcturus Therapeutics Holdings Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-8%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Arcturus Therapeutics Holdings Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-50%
Average Miss
What are analyst estimates?

See Also

Summary
ARCT intrinsic value, competitors valuation, and company profile.
DCF Valuation
ARCT stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ARCT stock valuation using valuation multiples.
Wall Street Estimates
ARCT price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ARCT stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ARCT's stock price target?
Price Target
68.98 USD

According to Wall Street analysts, the average 1-year price target for ARCT is 68.98 USD with a low forecast of 18.18 USD and a high forecast of 147 USD.

What is Arcturus Therapeutics Holdings Inc's Revenue forecast?
Projected CAGR
45%

The compound annual growth rate of Arcturus Therapeutics Holdings Inc's revenue for the next 3 years is 45%.

ALPHA SPREAD
Join more than 131,800+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.